H.H.H.W. Schmidt
Research projects
ERC Advanced Grant
EUROSTARS project
Publications
Most recent publications:
-
Aguirre-Plans, J., Pinero, J., Menche, J., Sanz, F., Furlong, L. I., Schmidt, H. H. H. W., ... Guney, E. (2018). Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology. Pharmaceuticals, 11(3), [61]. DOI: 10.3390/ph11030061
-
Egea, J., Fabregat, I., Frapart, Y. M., Ghezzi, P., Gorlach, A., Kietzmann, T., ... Daiber, A. (2018). European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) (vol 13, pg 94, 2017). Redox Biology, 14, 694-696. DOI: 10.1016/j.redox.2017.10.001
-
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M., Barbas, C., Daiber, A., ... Schmidt, H. H. H. W. (2018). Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacological Reviews, 70(2), 348-383. DOI: 10.1124/pr.117.014753
-
Casas, A. I., Geuss, E., Kleikers, P. W. M., Mencl, S., Herrmann, A. M., Buendia, I., ... Schmidt, H. H. H. W. (2017). NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage. Proceedings of the National Academy of Sciences of the United States of America, 114(46), 12315-12320. DOI: 10.1073/pnas.1705034114
-
Egea, J., Fabregat, I., Frapart, Y. M., Ghezzi, P., Gorlach, A., Kietzmann, T., ... Daiber, A. (2017). European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biology, 13, 94-162. DOI: 10.1016/j.redox.2017.05.007
-
Vonbank, A., Agewall, S., Kjeldsen, K. P., Lewis, B. S., Torp-Pedersen, C., Ceconi, C., ... Drexel, H. (2017). Comprehensive efforts to increase adherence to statin therapy. European Heart Journal, 38(32), 2473-2477b. DOI: 10.1093/eurheartj/ehw628
-
Ghezzi, P., Jaquet, V., Marcucci, F., & Schmidt, H. H. H. W. (2017). The oxidative stress theory of disease: levels of evidence and epistemological aspects. British Journal of Pharmacology, 174(12), 1784-1796. DOI: 10.1111/bph.13544
-
Gray, S. P., Jha, J. C., Kennedy, K., van Bommel, E., Chew, P., Szyndralewiez, C., ... Jandeleit-Dahm, K. A. M. (2017). Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease. Diabetologia, 60(5), 927-937. DOI: 10.1007/s00125-017-4215-5
-
Geis, C., Geuss, E., Sommer, C., Schmidt, H. H. H. W., & Kleinschnitz, C. (2017). NOX4 is an early initiator of neuropathic pain. Experimental Neurology, 288, 94-103. DOI: 10.1016/j.expneurol.2016.11.008
-
Kleinschnitz, C., Mencl, S., Kleikers, P. W. M., Schuhmann, M. K., Lopez, M. G., Casas, A. I., ... Schmidt, H. H. H. W. (2016). NOS knockout or inhibition but not disrupting PSD-95-NOS interaction protect against ischemic brain damage. Journal of Cerebral Blood Flow and Metabolism, 36(9), 1508-1512. DOI: 10.1177/0271678X16657094
Other publications:

H.H.H.W. Schmidt
Full professor - Key domain chair
Professor of Pharmacology Chairman Department of...
Pharmacology and Personalised Medicine, School for Cardiovascular Diseases, Fac. Health, Medicine and Life Sciences
+31(0)43 3881421